Kaur M, Lo S, Liu Y, Yip K
Cureus. 2024; 16(9):e69201.
PMID: 39398785
PMC: 11469534.
DOI: 10.7759/cureus.69201.
He X, You R, Shi Y, Zeng Z, Tang B, Yu J
Inflammopharmacology. 2023; 31(5):2269-2282.
PMID: 37429997
DOI: 10.1007/s10787-023-01275-0.
van de Ven N, Bongers S, Spijkerman R, Koenderman L, Leenen L, Hietbrink F
BMC Emerg Med. 2023; 23(1):28.
PMID: 36915043
PMC: 10010956.
DOI: 10.1186/s12873-023-00800-2.
Vordenbaumen S, Feist E, Rech J, Fleck M, Blank N, Haas J
Z Rheumatol. 2022; 82(Suppl 2):81-92.
PMID: 36520170
DOI: 10.1007/s00393-022-01294-2.
Rao S, Tsang L, Zhao M, Shi W, Lu Q
Front Med (Lausanne). 2022; 9:881431.
PMID: 36072947
PMC: 9442343.
DOI: 10.3389/fmed.2022.881431.
Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.
Kondo F, Sugihara T, Umezawa N, Hasegawa H, Hosoya T, Kimura N
Arthritis Res Ther. 2022; 24(1):92.
PMID: 35488289
PMC: 9052454.
DOI: 10.1186/s13075-022-02780-3.
Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.
Malengier-Devlies B, Metzemaekers M, Wouters C, Proost P, Matthys P
Front Immunol. 2021; 12:766620.
PMID: 34966386
PMC: 8710701.
DOI: 10.3389/fimmu.2021.766620.
An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.
Kim J, Ahn M, Jung J, Suh C, Kim H
Int J Mol Sci. 2021; 22(23).
PMID: 34884842
PMC: 8657670.
DOI: 10.3390/ijms222313038.
Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
Shimojima Y, Ichikawa T, Kishida D, Takamatsu R, Sekijima Y
Clin Exp Immunol. 2021; 206(2):184-195.
PMID: 34319596
PMC: 8506130.
DOI: 10.1111/cei.13648.
Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.
Jung J, Kim J, Suh C, Kim H
Front Immunol. 2020; 11:583513.
PMID: 33224145
PMC: 7674197.
DOI: 10.3389/fimmu.2020.583513.
Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.
Wang M, Jia J, Yang C, Hu Q
Chin Med J (Engl). 2019; 132(23):2856-2864.
PMID: 31856058
PMC: 6940076.
DOI: 10.1097/CM9.0000000000000538.
Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics.
Nogi S, Arinuma Y, Komiya A, Hashimoto A, Matsui T, Tohma S
Case Rep Rheumatol. 2019; 2018:2856546.
PMID: 30631629
PMC: 6304869.
DOI: 10.1155/2018/2856546.
[CD64 index as a marker of infection in patients with postoperative fever].
Vicente Lopez N, Fores Cachon R, Iranzo Valero R, Lerma Verdejo A, Munez Rubio E, Royuela Vicente A
Rev Esp Quimioter. 2018; 31(6):493-498.
PMID: 30421879
PMC: 6254475.
Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Sfriso P, Bindoli S, Galozzi P
Drugs. 2018; 78(12):1187-1195.
PMID: 30069732
DOI: 10.1007/s40265-018-0956-9.
Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options.
Gopalarathinam R, Orlowsky E, Kesavalu R, Yelaminchili S
Case Rep Rheumatol. 2016; 2016:6502373.
PMID: 27042373
PMC: 4794578.
DOI: 10.1155/2016/6502373.
Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.
Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Seve P
Immunol Res. 2014; 61(1-2):53-62.
PMID: 25388963
DOI: 10.1007/s12026-014-8561-9.
Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.
Mavragani C, Spyridakis E, Koutsilieris M
Int J Inflam. 2012; 2012:879020.
PMID: 22792508
PMC: 3390042.
DOI: 10.1155/2012/879020.
